This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link. Do Not Sell My Personal Information
A first scientific evaluation of aggregated care data from the Outpatient Partner Network was published this month in “Der Nervenarzt” – the official publication of the German Society of Neurology (DGN). The publication analyzes data on the provision of assistive devices for patients with amyotrophic lateral sclerosis (ALS) in the period from June 2011 to…

The AmbulanzPartner Akademie is once again offering a number of compact seminars for medical partners and care partners in 2015. This year’s seminars will focus on the modern provision of aids for complex neurological diseases such as amyotrophic lateral sclerosis, Parkinson’s disease and stroke. The seminars serve to improve the care of patients in the…

The module for medication processes has been online on AmbulanzPartner.de since February 12. From Q1/2105, the module will initially be used to digitally display medication supply processes in the pilot indications of amyotrophic lateral sclerosis, spasticity after stroke and multiple sclerosis. In the initial phase, the process module will be used for care processes in…
1,200 people with ALS in Germany currently use AmbulanzPartner for their care with remedies, aids, care services and medication. That is around 20% of all people living with ALS in Germany. This makesAmbulanzPartner the largest network for supporting people with ALS in Europe. The resulting data on care shows for the first time the differences…

The Outpatient Clinic for Motor Neuron Diseases at the Carl Gustav Carus University Hospital at the Technical University of Dresden has been a new medical partner in the OutpatientPartner Care Network since July 1, 2014. The outpatient clinic is a special consultation of the Neurological Outpatient Clinic and is headed by Priv.-Doz. Dr. med. Dr.…

AmbulanzPartner and Charité – Universitätsmedizin Berlin analyzed 1,254 patients with amyotrophic lateral sclerosis (ALS) to determine the rejection rates by health insurance companies and the regional differences in care. Between March 2011 and March 2014, 7,394 medical aids were prescribed by a specialist neurologist and recorded on the AmbulanzPartner.de internet portal. The rejection rate by…
The internet-supported medication supply for ALS has been very well received. Launched in August 2013, over 200 people with ALS are currently taking part in the module. In addition to an electronic medication plan, the nationwide medication supply in the AmbulanzPartner supply network also offers telephone advice from a specialist pharmacist and free delivery of…
The European research consortium Joint Programs – Neurodegenerative Diseases (JPND) is using the Internet portal AmbulanzPartner.de for the ALS-CarE project. The ALS-CarE joint project aims to improve the care of patients with amyotrophic lateral sclerosis (ALS) in Europe. Institutes and clinics at the universities in Dublin, London, Milan, Leuven, Munich and Berlin are involved in…
In a sub-project of the German Network for Motor Neuron Diseases (MND-Net), a joint project of the Federal Ministry of Education and Research (BMBF), AmbulanzPartner is used to collect care data from patients with amyotrophic lateral sclerosis (ALS). The project is being coordinated at Charité – Universitätsmedizin Berlin and is being carried out in cooperation…